Advertisement NewCardio names new president - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

NewCardio names new president

NewCardio, a cardiac diagnostic and services company, has appointed Vincent Renz as its new president. Mr Renz will oversee the company's commercialization effort, to include business development, client services, software development and quality assurance.

In addition, Mr Renz will play a key role in developing strategic partnerships and alliances. He will report directly to Branislav Vajdic, who continues as the company’s CEO.

Mr Renz has more than 26 years of experience in the information technology industry, specifically in the development and commercialization of technology products and services. He joins NewCardio from ClinPhone, a clinical technology organization recently acquired by Parexel International, a biopharmaceutical services organization.

Dr Vajdic said: “Adding an industry leader like Vinnie to our team is a win for NewCardio, its employees, customers and shareholders. He brings proven skills in the life sciences, health care and information technology industries, with particular expertise in business development, partnership formation and support of innovative software-based technologies.”